Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Clears Redesigned Olympus Duodenoscope As Olympus Readies To Replace Old Scopes

This article was originally published in The Gray Sheet

Executive Summary

FDA cleared a redesign of Olympus America’s TJF-Q180V duodenoscope, and new labeling, as the company prepared to replace the old devices at health care facilities. The changes are intended to “help reduce the risk of bacterial infections” from TJF-Q180V, implicated in three years of carbapenem-resistant Enterobacteriaceae outbreaks that sickened and killed hundreds of patients here and abroad.


Related Content

Scope Firms, FDA Faulted In 300-Page Senate Report Seeking Device Reforms


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst